Cardio Diagnostics Holdings is trading at $2.03, up 5.45% in pre-market, primarily reflecting broader risk-on sentiment.

  • The price is above the August 24 close of $1.93, reversing part of the prior session’s 5.17% decline.
  • No new company-specific announcement was identified for August 25; latest notable developments were the August 18 launch of its Iowa CLIA-certified laboratory and August 20 investor call announcement.
  • S&P 500, Nasdaq, and Dow futures were all higher by more than 0.5%; volume and activity-level data were unavailable.